pentobarbital will lessen the extent or outcome of buprenorphine subdermal implant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Closely. Keep track of individuals presently on buprenorphine subdermal implant who demand freshly-initiated procedure with CYP3A4 inducer for indications and indications of withdr